Financials

  • Market Capitalization 445.93 M
  • Employee 231
  • Founded 2005
  • CEO Linda Marban
  • Website www.capricor.com
  • Headquarter Delaware, United States
  • FIGI BBG000DZMK99
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-12.77
Relación precio/flujo de caja
—

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2922
TECX
Tectonic Therapeutic, Inc. - Common Stock
23.08 USD-1.07%+4.01%-21.47%+34.58%451.20 M USD
2924
PRTA
Prothena Corporation plc - Ordinary Shares
8.49 USD-3.96%+5.60%-5.14%-15.35%435.85 M USD
2931
EDIT
Editas Medicine, Inc. - Common Stock
2.85 USD-1.72%+7.95%+5.95%-24.00%437.70 M USD
2948
DMAC
DiaMedica Therapeutics Inc. - Common Stock
8.20 USD-1.56%-1.56%+26.35%+23.31%442.19 M USD

Noticias